Should You Buy Boundless Bio Inc (BOLD) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast BOLD stock price to rise
1 Analyst Rating
Wall Street analysts forecast BOLD stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.470
Low
4
Averages
4
High
4
Current: 1.470
Low
4
Averages
4
High
4
H.C. Wainwright
Buy
downgrade
$5 -> $4
AI Analysis
2025-08-11
Reason
H.C. Wainwright
Price Target
$5 -> $4
AI Analysis
2025-08-11
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Boundless Bio to $4 from $5 and keeps a Buy rating on the shares following the Q2 report.
Goldman Sachs
Richard Law
initiated
2025-07-24
Reason
Goldman Sachs
Richard Law
Price Target
2025-07-24
initiated
Reason
Goldman Sachs analyst Richard Law initiated coverage of Boundless Bio with an Early-Stage Biotech rating, saying the company's combo approach for its lead asset BBI-355 comes with high risk.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BOLD
